cisplatin
pharmaceutical drug
Facts
15 properties- Instance of
- type of chemical entity
- Subclass of
- chemical compound
- Part of
- response to cisplatin, cellular response to cisplatin
- Has use
- medication
- Canonical SMILES
- Cl[Pt]([NH3])([NH3])Cl
- Chemical formula
- Cl₂H₆N₂Pt
- Has part(s)
- platinum
- Isomeric SMILES
- Cl[Pt@SP1]([NH3])([NH3])Cl
- Legal status (medicine)
- boxed warning
- Mass
- 298.955595 Da
- Medical condition treated
- lung oat cell carcinoma, head and neck cancer, breast cancer, esophageal cancer, Hodgkin's lymphoma, mixed cellularity, osteosarcoma, amelanotic melanoma, lung benign neoplasm, multiple myeloma, spindle cell sarcoma, prostate cancer, lymphosarcoma
+19 more
ovarian cancer, stomach cancer, testicular cancer, bladder cancer, subependymal giant cell astrocytoma, neuroblastoma, germ cell cancer, transitional cell carcinoma, tongue squamous cell carcinoma, hepatoblastoma, head and neck squamous cell carcinoma, laryngeal cancer, non-small-cell lung carcinoma, gastric adenocarcinoma, bone sarcoma, neuroblastoma, susceptibility to, bladder cancer (1978–present), ovarian cancer (1978–present), testicular cancer (1978–present) - Pregnancy category
- US pregnancy category D
- Significant drug interaction
- furosemide, tobramycin, fosphenytoin, phenytoin
- Stylized name
- CISplatin
🏷️ Also known as
en CIS-DDP
en cis-diamminedichloroplatinum(II)
en Platinol-AQ
en Platinol
en cisplatin
en CDDP
en Cis-DDP
ar سيسبلاتين
cs cisplatina
de (SP-4-2)-Diammindichloridoplatin(II)
de H6Cl2N2Pt
el σισπλατίνη
es Cisplatino
fa سیس پلاتین
fi Cis-diammiinidikloroplatina(II)
fi Kisplatiini
fi sisplatiini
fr 15663-27-1
fr Cis-diamminedichloroplatinum
fr cisplatine
🔖 Identifiers · 51
- OpenAlex ID
- C2778239845
- ATC code
- L01XA01
- Brockhaus Enzyklopädie online ID
- cisplatin
- CA PROP 65 ID
- cisplatin
- CAMEO Chemicals ID
- 24020
- CAS Registry Number
- 15663-27-1
- ChEBI ID
- 27899
- ChEMBL ID
- CHEMBL11359
- ChemSpider ID
- 76401
- DSSTOX compound identifier
- DTXCID90227183
- DSSTox substance ID
- DTXSID50275807
- DrugBank ID
- DB00515
Show all 51 identifiers +39
- EC number
- 239-733-8
- ECHA Substance Infocard ID
- 100.036.106
- Electronic Essential Medicines List medicine ID
- 79
- Freebase ID
- /m/04xnqp
- Gmelin number
- 2519
- Gran Enciclopèdia Catalana ID
- cisplati
- Gran Enciclopèdia Catalana ID (former scheme)
- 0090769
- Guide to Pharmacology Ligand ID
- 5343
- HSDB ID
- 3939
- Human Metabolome Database ID
- HMDB0014656
- IEDB Epitope ID
- 194799
- InChIKey
- LXZZYRPGZAFOLE-UHFFFAOYSA-L
- J9U entity ID
- 987007286296705171
- KEGG ID
- D00275
- MeSH descriptor ID
- D002945
- MeSH tree code
- D01.210.375, D01.625.125, D01.710.100
- MedlinePlus drug identifier
- a684036
- Microsoft Academic ID (discontinued)
- 2778239845
- NALT ID
- 10462
- NDF-RT ID
- N0000146476
- NE.se ID
- cisplatin
- NL CR AUT ID
- ph707356
- PDB ligand ID
- CPT
- PatientsLikeMe treatment ID
- cisplatin
- Probes And Drugs ID
- PD001382
- PubChem CID
- 5460033
- Quora topic ID
- Cisplatin
- RTECS number
- TP2450000
- RxNorm CUI
- 2555
- UN number
- 3288
- UNII
- Q20Q21Q62J, BW0OY6ZTD4
- UNSPSC code
- 51111506
- UniChem compound ID
- 292460
- Wellcome Collection concept ID
- a3enevfa
- WikiProjectMed ID
- Cisplatin
- ZVG number
- 490577
🔗 Connections
Medical condition treated 19
← Drug or therapy used for treatment 19
Significant drug interaction 7
← Significant drug interaction 7
Subject has role 6
Has part(s) 1
Has use 1
Legal status (medicine) 1
Subclass of 1
Press Enter · cited answer in seconds
0 sources
Summary
cisplatin is a type of chemical entity[1]. cisplatin is a type of chemical compound[2].
Key Facts
- Canonical SMILES: ClPt([NH3])ClPt([NH3])Cl">[3]
- Chemical formula: Cl₂H₆N₂Pt[4]
- Part of: response to cisplatin[5], cellular response to cisplatin[6]
- Has use: medication[7]
- Has part(s): platinum[8]
- Significant drug interaction: furosemide[9], tobramycin[10], fosphenytoin[11], phenytoin[12]
- Isomeric SMILES: ClPt@SP1([NH3])ClPt@SP1([NH3])Cl">[13]
- Mass: 298.955595 dalton[14]
- Medical condition treated: lung oat cell carcinoma[15], head and neck cancer[16], breast cancer[17], esophageal cancer[18], Hodgkin's lymphoma, mixed cellularity[19], osteosarcoma[20], amelanotic melanoma[21], lung benign neoplasm[22], multiple myeloma[23], spindle cell sarcoma[24], prostate cancer[25], lymphosarcoma[26], ovarian cancer[27], stomach cancer[28]